Bifunctional monitoring in patients with combined pathology of bronchopulmonary and cardiovascular systems
Abstract
The article discusses problems of diagnosis and treatment of bronchial asthma (BA) and chronic obstructive bronchitis (COB) combined with ischaemic heart disease (IHD). A bifunctional monitoring method wasoffered which allowed evaluation of myocardial bioelectric activity under bronchial obstruction. It was shown that worsening of bronchial obstruction is accompanied by rising of myocardial ectopic activity in BA and COB patients irrespective of IHD. Besides that, the ischaemic myocardial disorders were enhanced in BA and COB when combined with IHD.
About the Authors
N. R. Paleev
МОНИКИ им. М.Ф. Владимирского
Russian Federation
Russian Federation
N. K. Chereiskaya
МОНИКИ им. М.Ф. Владимирского
Russian Federation
Russian Federation
S. I. Fedorova
МОНИКИ им. М.Ф. Владимирского
Russian Federation
Russian Federation
I. A. Afanasieva
МОНИКИ им. М.Ф. Владимирского
Russian Federation
Russian Federation
References
1. Алексеенко З.К. Особенности клинического течения и диагностики ИБС на фоне хронических обструктивных заболеваний легких: Автореф. дис. ... д-ра мед. наук. Днепропетровск; 1991.
2. Аля Хусейн Мади Аль-Салами. Клинико-функциональные особенности бронхиальной астмы больных в пожилом и старческом возрасте: Автореф. дис. ... канд. мед. наук. СПб; 1992.
3. Кахновский И.М., Маринин В.Ф., Сорокина Л.А., Маркова З.С. Кардиомониторирование у больных бронхиальной астмой на фоне приема сальбена. Тер. арх. 1996; 68 (3): 50-52.
4. Лоуренс Д.Р., Бенитт П.Н. Клиническая фармакология. М.: Медицина; 1993; т.2: 285-332.
5. Beasley R. Beta-agonists and New Zealand asthma mortality. Lancet 1991; 337 (9747): 982-983.
6. Costa R., Marino A. Recent acquisitions on the pharmacology and therapeutic uses of theophylline with special reference to cardiovascular effects. Clin. Ter. 1991; 136 (4): 233-244.
7. Dijkman J.H., Leiden M. The use of beta-agonists and the risk of death from asthma. Eur. Respir. Topic 1994; 1 (1): 18.
8. Droste C., Roskamm H. Silent myocardial ischemia. Am. Heart J. 1989; 118 (5): 1087-1092.
9. Ernst P., Spitzer W., Suissa S. et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. J.A.M.A. 1992; 268: 3462-3464.
10. Hall I.P., Woodhead M. Johnston D.A. Effect of nebulised salbutamol on cardiac arrhythmias in subjects with sever chronic airflow obstruction- a controlled study. Am. Rev. Respir. Dis. 1990; 141 (4, pt 2): 752.
11. Katz A., Buskila D., Sukenik 3. Oral mexiletine-theophylline interaction. Int. J. Cardiol. 1987; 17 (2): 227-228.
12. Lewczuk J., Piszko P. Chronic obstructive lung disease and ischemic heart disease. Pneumonol. Pol. 1989; 57 (6): 377-380.
13. Mikhail M .S., Hunsinger S.Y., Goodvin S.R., Loughlin G.M. Myocardial ischemia complicating therapy of status asthmaticus. Clin. Pediatr. 1987; 26 (8): 419-421.
14. Milton J. Complications of corticosteroids. Br. J. Hosp. Med. 1996; 55 (3): 147.
15. Myers K.E., Bogden P.E. Bronchodilators for patients with ischemic heart disease. How to avoid complications? Postgrad. Med. 1989; 86 (5): 324-326.
16. Petrov D. The clinico-diagnostic and therapeutic problems of patients with bronchial asthma combined with ischemic heart disease. Vntr. Boles. 1989; 28 (6): 21-25.
17. Rawson N.S., Malcolm E. Validity of the recording of ischemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat. Med. 1995; 14 (24): 2627-2643.
18. Radoff G. Clinical problem solving: the appropriate degree of diagnostic certainty? N. Engl. J. Med. 1995; 332 (8): 538.
19. Schaner J., Harksei B., Harksei K. Effect of secondary bronchopulmonary disease on the performance and course of rehabilitation of patients with myocardial infarct. Z. Ges. Inn. Med. 1987; 42 (7): 182-187.
20. Sears M.R., Taylor D.R., Print C.G. et al. Regular inhaled ß-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396.
21. Sears V.R. Exacerbations of asthma in patients on salmeterol. Ibid. 1991; 337 (8746): 234.
22. Spitzer W.O., Suissa S., Ernst P. et al. The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 1992; 326: 501-506.
23. Toren K., Lindholm N.B. Do patients with severe asthma run an increased risk from ischemic heart disease? Int. J. Epidemiol. 1996; 25 (3): 617-620.
Review
For citations:
Paleev N.R., Chereiskaya N.K., Fedorova S.I., Afanasieva I.A. Bifunctional monitoring in patients with combined pathology of bronchopulmonary and cardiovascular systems. PULMONOLOGIYA. 2003;(4):63-70. (In Russ.)
Views:
156
Email this article 